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 Chapter 16 
 Sample Preparation for N-Glycosylation Analysis 
of Therapeutic Monoclonal Antibodies by Electrophoresis 
 Ákos  Szekrényes ,  Jan  Partyka ,  Csaba  Varadi ,  Jana  Krenkova , 
 Frantisek  Foret , and  András  Guttman 
 Abstract 
 There are a considerable number of biopharmaceuticals that have been approved for clinical use in the past 
decade. Over half of these new generation drugs are glycoproteins, such as monoclonal antibodies or other 
recombinant glycoproteins, which are mostly produced in mammalian cell lines. The linked carbohydrate 
moieties affect not only their physicochemical properties and thermal stability but also crucial features like 
receptor-binding activity, circulating half-life, as well as immunogenicity. The structural diversity of these 
attached glycans can be manifested in altered monosaccharide composition and linkages/positions among 
the monosaccharide building blocks. In addition, as more and more biosimilar products hit the market, 
understanding the effects of their glycosylation modifi cation has become a recent target in effi cacy and 
safety issues. To ensure consistent quality of these products, glycosylation profi les have to be monitored 
and controlled in all steps of the manufacturing process, i.e., from clone selection to lot release. In this 
paper, we describe some of the recently introduced and commonly used sample preparation techniques for 
capillary electrophoresis (CE)-based profi ling and structural elucidation of N-glycans. The presented pro-
tocols include protein A affi nity partitioning of monoclonal antibodies (mAbs), enzymatic release of the 
N-linked glycans, labeling of the liberated carbohydrates, reaction mixture purifi cation techniques to 
remove the excess labeling reagent, and high-resolution and rapid capillary electrophoresis-laser-induced 
fl uorescence (CE-LIF)-based profi ling of the labeled and purifi ed N-glycans. 
 Key words  Biopharmaceuticals ,  Therapeutic monoclonal antibody ,  N-glycan analysis ,  Fluorophore 
labeling ,  Capillary electrophoresis 
1  Introduction 
 Glycosylation is one of the most important and complex posttrans-
lational modifi cations on the majority of new biotherapeutic drugs. 
Glycoproteins are typically produced as mixtures of different gly-
coforms having the same polypeptide backbone but differing in 
glycosylation site specifi city (macroheterogeneity) and in the struc-
tures at a same site (microheterogeneity) [ 1 ]. It is well known that 
these attached carbohydrate chains are very important from the 
point of view of quality by design (QbD) in biopharmaceutical 
184
manufacturing because of their signifi cant infl uence on activity and 
effi cacy. Since glycan biosynthesis and processing are exquisitely 
responsive to the host cell type and growth environment, changes 
may occur in the glycosylation profi le of different production 
batches of the innovative drug but also in their follow-up versions 
(biosimilars) [ 2 ]. Meanwhile, there have been reports of adverse 
events caused by nonhuman glycosylation moieties due to the 
presence of immunogenic residues, such as α-1,3-Gal or 
N-glycolylneuraminic acid [ 3 ]. Therefore, it is crucial to maintain 
the carbohydrate distribution profi le of glycosylated biopharma-
ceuticals for effi cient and safe use [ 4 ,  5 ]. Advances are continually 
being made in the biotechnology industry to minimize glycan het-
erogeneity and improve the sensitivity and specifi city of the analyti-
cal assays used to identify and quantify possible glycosylation 
changes. In spite of the fact that several analytical techniques and 
assays have already been implemented and validated for the charac-
terization of these complex molecules, rapid and comprehensive 
profi ling and quantitation of all glycoforms are still a challenging 
task. One of the most powerful bioseparation techniques for 
detailed N-linked glycosylation analysis of biotherapeutics is capil-
lary electrophoresis combined with laser-induced fl uorescent 
(CE-LIF) detection [ 6 – 10 ]. Different CE-based assays can be used 
to characterize the drug during the manufacturing process, trou-
bleshoot production problems, and demonstrate biosimilarity or 
comparability. 
 In this protocol, we introduce some of the most effi cient sam-
ple preparation methods for CE-LIF analysis of complex carbohy-
drates. Usual protocols start with affi nity partitioning of the 
formulated or crude monoclonal antibody product using protein A 
resins. This step is essential for the complete removal of all addi-
tives and formulation ingredients, which can affect glycan labeling 
or the consequent CE-LIF analysis. Next, we describe some of the 
commonly used in-solution N-glycan release method using 
peptide- N-glycosidase F (PNGase F). The affi nity partitioning and 
glycan release steps are followed by fl uorophore labeling of the 
liberated glycans and the removal of the excess labeling material. 
Finally, we describe the optimal capillary electrophoresis analysis 
parameters for the labeled N-linked glycans in respect to regular 
profi ling (high resolution) and rapid screening (low resolution). 
2  Materials 
 Always use HPLC grade or ultrapure water (18 MΩ cm at 25 °C) 
for all solutions and buffers in all procedures. In addition, all 
reagents should be microbiology or HPLC grade unless otherwise 
stated. The use of powder-free, nitrile gloves for all sample  handling 
procedures is important too. Ensure that all glass, plasticware, 
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and solvents are free of glycosidases and possible environmental 
carbohydrate contaminations. All procedures should be performed 
using appropriate personal safety protection, laboratory coat, 
eyeglasses, and nitrile gloves. The labeling reactions should be 
performed in a fume hood. 
  1.  Crude or formulated mAb sample. 
  2.  1× PBS buffer, pH 7.2. 
  3.  200+ PhyTip protein A columns with 5 μL bed volume 
(Phynexus Inc., San Jose, CA). 
 All PhyTip protein A columns are supplied with buffers and 
reagents including:
 Capture buffer : provided for those situations where additional 
buffer is needed to supplement sample volume and ensure 
correct capture pH. 
 Wash buffer I : phosphate buffer solution, pH 7.4. 
 Wash buffer II : saline solution. 
 Enrichment buffer : phosphate buffer solution, pH 2.5. 
 Neutralization buffer : Tris buffer solution, pH 9.0. 
  4.  Rainin PureSpeed (Rainin Instrument LLC, Oakland, CA, 
USA) electronic semiautomated multichannel pipette (8 or 12 
channels). 
  5.  96-well plate, 0.5 mL/well capacity. 
  6.  0.2-mL fl at cap PCR tubes. 
  7.  100 mM sodium carbonate buffer (pH 9.0) to replace the 
neutralization buffer. 
  8.  20 mM sodium carbonate buffer, pH 7.0. 
  9.  10 % acetic acid in water to replace the enrichment buffer. 
 10.  10 kDa cutoff spin fi lters (Nanosep 10k Omega, Pall, Port 
Washington, NY, USA). 
 11.  Microcentrifuge equipped with a rotor suitable for 2.0-mL 
microfuge tubes and capable to provide 17,200 ×  g . 
 12.  Centrifugal vacuum evaporator (e.g., SpeedVac). 
  1.  50 mM dithiothreitol (DTT) in water. 
  2.  50 mM iodoacetamide (IAM) in water. 
  3.  20 mM NaHCO 3 , pH 7.0. 
  4.  Peptide-N-glycosidase F (ProZyme, Hayward, CA, USA). 
  5.  0.2-mL fl at cap PCR tubes. 
  6.  PCR thermocycler or other general microvial-based heating 
devices capable to provide stable 65 and 37 °C temperature. 
  7.  15 % acetic acid in water. 
2.1  Protein A Affi nity 
Partitioning Using 
PhyTip 200+ Columns
2.2  In-Solution 
N-Glycan Release 
and APTS Labeling 
of N-Glycans
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  8.  8-Aminopyrene-1,3,6-trisulfonic acid (APTS) (Beckman 
Coulter, Brea, CA, USA). 
  9.  1 M sodium cyanoborohydride in tetrahydrofuran (THF). 
 10.  10 mg/mL APTS solution in 15 % acetic acid. 
 11.  10 kDa cutoff spin fi lters (Nanosep 10 k Omega, Pall, Port 
Washington, NY, USA). 
 12.  Microcentrifuge equipped with a rotor suitable for 2.0-mL 
microfuge tubes and capable to provide 17,200 ×  g . 
 13.  Centrifugal vacuum evaporator. 
 14.  Vortex mixer. 
 15.  Pipettors and disposable pipette tips (P5/P10, P200, and 
P1000). 
 16.  Miscellaneous labware for buffers and dilutions. 
  1.  1000+ PhyTip normal phase columns with 20 μL bed volume. 
  2.  Rainin multichannel 100–1000-μL pipettor (8 channels). 
  3.  Acetonitrile (100 %, HPLC grade). 
  4.  20 % acetonitrile in water. 
  5.  95 % acetonitrile in water. 
  6.  96-deep-well plate 2 mL/well. 
  7.  Centrifugal vacuum evaporator. 
  8.  0.2-mL fl at cap PCR tubes. 
  1.  GlykoPrep Digestion Module (ProZyme) includes:
 ●  Digestion (RX) cartridges (24 cartridges). 
 ●  Immobilization reagent set. 
 ●  Denaturation reagent. 
 ●  Blocking reagent. 
 ●  Digestion reagent set. 
 ●  N-Glycanase. 
 ●  25× digestion buffer. 
 ●  Finishing reagent. 
 ●  Aluminum sealing fi lm. 
  2.  GlykoPrep APTS Cleanup Module (ProZyme) includes:
 ●  5× APTS sample loading buffer. 
 ●  Cleanup (CU) cartridges (24 cartridges). 
  3.  Acetonitrile (HPLC grade). 
  4.  Microcentrifuge (capable of 50–1,000 ×  g ) and rotor suitable 
for 1.5-/2.0-mL microcentrifuge vials. 
  5.  Heater and heating block accommodating 0.2-mL PCR tubes. 
  6.  Centrifugal vacuum evaporator. 
2.3  APTS Cleanup 
Using 1000+ PhyTip 
with 20 μL Normal 
Phase Resin
2.4  Sample 
Preparation Using 
GlykoPrep Rapid 
N-Glycan Preparation 
Platform
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  7.  Vortex mixer. 
  8.  Pipettors and disposable pipette tips (P5/P10, P200, and P1000). 
  9.  Miscellaneous labware for buffers and dilutions. 
  1.  Beckman Coulter PA 800  plus Pharmaceutical Analysis System, 
equipped with LIF detection (solid-state 488-nm laser) and 
32 Karat software v.8.0 or higher. 
  2.  Carbohydrate separation buffer (Beckman Coulter). 
  3.  N–CHO-coated capillary, 50 μm ID (Beckman Coulter). 
  4.  Sample vials. 
  5.  2.0-mL plastic vials. 
  6.  Vial caps. 
  7.  Capillary cartridge equipped with N–CHO-coated capillary 
with a total length of 60.2 cm (effective length 50.2 cm). 
3  Methods 
  1.  Dilute the crude or formulated mAb sample to 2 mg/mL 
using the PBS buffer, pH 7.2 ( see  Note 1 ). 
  2.  Transfer 220 μL of capture buffer to the fi rst row of the 
96-well plate. 
  3.  Transfer 100 μL of diluted mAb sample and 120 μL of  capture 
buffer to each well in the second row. Mix the sample gently 
by pipetting. 
  4.  Fill up the wells in the third row with 220 μL of  wash buffer I . 
  5.  Fill up the wells in the fourth row with 220 μL of  wash buffer II . 
  6.  Fill up the wells in the fi fth row with 25 μL of 10 % acetic acid. 
  7.  Conditioning (fi rst row): 200 μL of capture buffer over the 
resin bed for one cycle at a fl ow rate of 250 μL/min. 
  8.  Capture (second row): capture the IgG by passing 200 μL of 
sample solution through the resin bed in four cycles at a fl ow 
rate of 100 μL/min. 
  9.  Purifi cation (third and fourth row): pass 100 μL of protein A 
wash buffer I through the resin bed in one cycle at a fl ow rate 
of 250 μL/min followed by a second wash with 200 μL wash 
buffer II, passing through the resin bed in one cycle at a fl ow 
rate of 250 μL/min. It is essential to use wash buffer II as it 
exchanges the pH 7.4 buffer of wash buffer I and in doing so 
ensures effective low pH elution during the enrichment step. 
 10.  Enrichment (fi fth row): elute the captured IgG with 15 μL 
10 % acetic acid solution (pH ~2.5) passed through the resin 
bed in four cycles at a fl ow rate of 100 μL/min. Neutralize the 
sample by the addition of 175 μL of 100 mM sodium carbon-
ate buffer (pH 9.0). 
2.5  CE-LIF Analysis 
of APTS-Labeled 
N-Glycans
3.1  Protein A Affi nity 
Partitioning of mAbs
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 11.  Wash the membrane of the 10 kDa cutoff spin fi lter with 
250 μL of water for 15 min at 17,200 ×  g . 
 12.  Pipette the sample onto the membrane and centrifuge for 
15 min at 17,200 ×  g . 
 13.  The sample is washed three times with 250 μL of water by 
spinning for 15 min at 17,200 ×  g ( see  Note 2 ). 
 14.  The desalted proteins are recovered from the membrane by 
inversion of the cartridge—to a new tube—and centrifugation 
at 1,320 ×  g for 4 min ( see  Note 3 ). 
 15.  To increase the recovery, invert the cartridge again—back to 
the original position—pipette 50 μL of water onto the mem-
brane, vortex it for 1 min, invert the cartridge, and centrifuge 
at 1,320 ×  g for 4 min. Repeat this step two times ( see  Note 4 ). 
 16.  After the desalting step, dry the recovered mAb sample in the 
centrifugal vacuum evaporator (heat setting turned to the off 
position) using continuous vacuum. 
  1.  Dissolve the dry protein samples in 45 μL of 20 mM sodium 
carbonate buffer, pH 7.0. 
  2.  Add 5 μL of 50 mM dithiothreitol (DTT) to the sample and 
incubate at 65 °C for 15 min. 
  3.  After the incubation step, add 5 μL of 50 mM iodoacetamide 
(IAM) to the sample and keep in the dark for 10 min at room 
temperature (RT). 
  4.  Add 2 μL 2.5 U/mL of N-glycanase solution to the sample 
and incubate for 2 h to overnight at 37 °C. 
  5.  Wash the membrane of the 10 kDa cutoff spin fi lter with 
250 μL of water for 15 min at 17,200 ×  g . 
  6.  Pipette the sample onto the membrane and centrifuge for 
15 min at 17,200 ×  g ( see  Note 5 ). 
  7.  Wash the membrane again with 50 μL of water for 15 min at 
17,200 ×  g . 
  8.  Collect the fl ow through and transfer it to a 0.2-mL clean 
PCR tube. 
  9.  Dry the clean released glycans in a centrifugal vacuum evapo-
rator (heat setting turned to off position). 
  1.  Dissolve the dry protein sample in 50 μL of 20 mM sodium 
carbonate buffer, pH 7.0. 
  2.  Add 50 μL of denaturation reagent to the protein solution. 
Mix well by pipetting up and down several times. 
  3.  Incubate at room temperature for at least 5 min. 
  4.  Nest the cartridge in a 0.5-mL screw cap microtube. 
3.2  In-Solution 
N-Glycan Release
3.3  N-Glycan 
Release Using 
GlykoPrep Digestion 
(RX) Cartridges
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  5.  Pipette 50 μL of 100 % acetonitrile into the sample cup of the 
RX cartridge. 
  6.  Place the tube in a centrifuge and spin at 300 ×  g for 3 min. 
  7.  Pipette 150 μL of denaturation reagent into the sample cup of 
each cartridge. 
  8.  Spin at 1,000 ×  g for 2 min. 
  9.  Empty the fl ow through by lifting each RX cartridge and 
removing the liquid collected in the microtube below. Dispose 
off this liquid and return the cartridge to the tube. 
 10.  Load 100 μL of the denatured mAb sample into the sample 
cup of each RX cartridge. 
 11.  Spin at 50 ×  g until all sample cups are empty (~15 min). 
 12.  Empty the fl ow through as described in  step 9 . 
 13.  Pipette 50 μL of blocking reagent into the sample cup of each 
RX cartridge. 
 14.  Spin at 300 ×  g for 3 min. 
 15.  Pipette 50 μL of digestion buffer (1× concentrated) into the 
sample cup of each RX cartridge. 
 16.  Spin at 300 ×  g for 3 min. 
 17.  Prepare the digestion and elution assembly by nesting each 
PCR tube into 0.5-mL tubes and nesting that within a 2.0-mL 
microcentrifuge tube. 
 18.  Transfer the RX cartridge into the corresponding digestion 
and elution assemblies and return to the centrifuge. Dispose 
the microtubes and the fl ow through. 
 19.  Pipette 10 μL of enzyme solution (2.5 μL of N-glycanase and 
7.5 μL of 1× digestion buffer) into the sample cup of the RX 
cartridge. 
 20.  Spin at 300 ×  g for 3 min; do not discard the fl ow through. 
 21.  Transfer the PCR tubes with the RX cartridges to a 45 °C 
PCR heat block and incubate for 30 min. 
 22.  Remove the PCR tubes with RX cartridges from the heat 
block and return to the digestion and elution assembly. 
 23.  Pipette 15 μL of fi nishing reagent into the sample cup of each 
RX cartridge. 
 24.  Spin at 300 ×  g for 3 min. 
 25.  Remove RX cartridge from the PCR tube. The eluted 
N-glycans are now in the PCR tubes; do not discard. 
 26.  Open the PCR tubes, return them to the digestion assembly 
(minus the RX cartridge), and dry the N-glycans in a centrifu-
gal vacuum evaporator (heat setting turned to the off position) 
for 30 min or until fully dry. 
Sample Preparation for N-Glycosylation Analysis of Therapeutic Monoclonal…
190
  1.  Add 4 μL of 10 mg/mL APTS (in 15 % acetic acid) to the 
dried sugars. 
  2.  Add 2 μL of 1 M NaBH 3 CN (in THF) to the sample ( see  Note 6 ). 
  3.  Incubate the reaction mixture at 37 °C overnight. For nonsi-
alylated glycoproteins, incubation at 55 °C for 2 h is suffi cient. 
  1.  Add 100 μL of water to the labeled samples and mix it by 
pipetting up and down several times. Transfer the mixture to 
the third row of the plate (Fig.  1 ) and add 900 μL acetonitrile 
to it. Mix the sample well again. 
  2.  Prepare the elution (20 % acetonitrile in water) and the wash-
ing solutions (95 % acetonitrile in water) and fi ll up the 
96-deep-well plate as shown in Fig.  1 ( see  Note 7 ). 
  3.  Insert the 1000+ DPA-6S normal phase PhyTip columns 
(20 μL bed volume) to the multichannel pipettor. 
  4.  Perform conditioning in the fi rst row (Fig.  1 ) by passing 
900 μL of elution solution through the resin bed four times. 
  5.  Equilibrate the columns by passing 900 μL of washing 
solution over the resin bed for four times in the second row 
in Fig.  1 . 
3.4  APTS Labeling 
of the Released 
N-Glycans
3.5  Removal 
of Excess APTS Using 
Normal Phase 
Columns
 Fig. 1  Reagent distribution in a deep-well plate for labeling reagent cleanup 
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  6.  Load the labeled glycans to the columns by pipetting 900 μL 
of sample mixture through the resin bed ten times (Fig.  1 , 
third row). 
  7.  Wash off the salts and excess labeling reagent by pipetting 
900 μL of washing solution through the resin bed ten times. 
Repeat this step six times, always using fresh solution in a new 
row (Fig.  1 , fourth to ninth row). 
  8.  Elute the APTS-labeled glycans by passing 180 μL elution 
solution through the resin bed three times. Repeat this step in 
the next two rows (Fig.  1 , 10th to 12th row). 
  9.  Collect the eluted sample from the elution positions to a 2.0- 
mL tube and dry it in a centrifugal vacuum evaporator (heat 
setting turned to the off position). 
 10.  Dissolve the dried samples in 25 μL HPCE grade water and 
proceed to capillary electrophoresis analysis. 
  1.  Prepare 5 mL of APTS sample load buffer by adding 1 mL of 
5× APTS sample load buffer to a small, glass graduated cylin-
der. Bring the volume up to 5 mL with 100 % acetonitrile. 
  2.  Dissolve the dried and labeled glycan samples in 200 μL of 
APTS sample load buffer. Pipette it up and down a couple of 
times to mix well. 
  3.  Add 200 μL of APTS sample load buffer to each N-glycan 
sample in the PCR tubes. Pipette up and down to mix. 
  4.  Transfer each N-glycan sample into the sample cup of a CU 
cartridge. Place the CU cartridge into a 0.5-mL tube by nest-
ing within a 2.0-mL microcentrifuge tube. 
  5.  Spin at 300 ×  g for 3 min or until the sample cup of each CU 
cartridge is empty. 
  6.  Discard the fl ow through and spin at 300 ×  g for 3 min again. 
  7.  Pipette 200 μL of APTS sample load buffer into the sample 
cup of each CU cartridge. 
  8.  Spin at 300 ×  g for 3 min. 
  9.  Discard the fl ow through and repeat  steps 6 and  7 again. 
 10.  Place the CU cartridge to a clean 0.2-mL PCR tube and nest 
this back to the 2.0-mL microcentrifuge tube, which is already 
containing the 0.5-mL tube. 
 11.  Pipette 25–50 μL of ultrapure water into the sample cup of 
each CU cartridge. 
 12.  Spin at 1,000 ×  g for 3 min. The PCR tube now contains the 
purifi ed labeled N-glycans; do not discard. 
 13.  N-Glycan samples are now ready for capillary electrophoresis 
analysis. If not analyzed immediately, store sealed at −20 °C in 
the dark. 
3.6  Cleanup 
of the Fluorophore-
Labeled Glycans by 
APTS Cleanup 
Modules
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  1.  Weigh and dissolve 5 mg of glucose ladder standard (G20, 
supplied with the N–CHO Carbohydrate Kit) in 80 μL deion-
ized water in 1.5-mL microcentrifuge tube. Sonicate if 
necessary. 
  2.  Aliquot at least ten 2 μL portions of the glucose ladder stan-
dard solution to 0.5-mL microcentrifuge vials and dry them in 
a centrifugal vacuum evaporator. The dried glucose ladder can 
be stored at room temperature or used immediately. 
  3.  Label the ladder standard as described under Subheading  3.4 
and proceed with sample cleanup. 
  4.  Transfer the APTS-labeled samples and standards to a 0.2-mL 
sample tube (Beckman Coulter), nest the tubes to 2-mL plas-
tic vials, and cap them tight. Place the sample vials to the sam-
ple tray and record their actual positions in the methods 
timetable. 
  5.  Fill the appropriate reagents into vials as follows:
 ●  1.5 mL of ultrapure water into H 2 O vial (four vials). 
 ●  1.5 mL of carbohydrate separation buffer into Gel-R vial 
(one vial). 
 ●  1.3 mL of carbohydrate separation buffer into Gel-S vial 
(two vials). 
 ●  0.8 mL of ultrapure water into waste vial (one vial). 
 Place the vials in the buffer tray and set up their actual 
 positions in the methods timetable. 
  6.  Set up the initial detection and separation parameters as 
follows:
 ●  Detection: laser-induced fl uorescence. 
 ●  Wavelength excitation, 488 nm; emission, 520 nm. 
 ●  Data rate: 4 Hz. 
 ●  Dynamic range: 100 RFU (relative fl uorescence units). 
 ●  Filter setting: normal. 
 ●  Peak width: 16–25. 
  1.  Rinse the capillary with buffer for 3 min at 30 psi from gel 
buffer (Gel-R vial for rinse) vial to waste vial. 
  2.  Inject the sample at 0.5 psi for 5 s from sample vial to buffer 
vial (Gel-S vial for separation). 
  3.  Wait for 0.2 min with vials fi lled with ultrapure water. This 
step dips the capillary in water to protect against sample car-
ryover. Change the rinse water vials if they are contaminated. 
  4.  Separation step: 20 min from gel buffer vial to gel buffer vial 
(Gel-S vial for separation). The applied voltage should be 
30 kV, with REVERSED polarity (anode at the detection side) 
with 0.17 min ramp time. 
3.7  CE-LIF Analysis 
of APTS-Labeled 
N-Glycans
3.7.1  Preparing 
the Glucose Ladder 
Standard (G20)
3.7.2  Performing 
the High- Resolution CE-LIF 
Analysis
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  5.  Autozero at 1.0 min. 
  6.  End at 20.0 min. 
  7.  An example of a high-resolution CE-LIF analysis of APTS- 
labeled IgG N-glycans performed on 50 cm separation length 
is shown in Fig.  2 with the corresponding glycan structures of 
the peaks. 
  1.  Rinse the capillary with buffer for 3 min at 30 psi from gel 
buffer (Gel-R vial for rinse) vial to waste vial. 
  2.  Inject the sample at 0.5 psi for 5 s from sample vial to buffer 
vial (Gel-S vial for separation). When injecting from the 10 cm 
effective length side of the capillary, make sure that the tray 
layout has changed accordingly. 
  3.  Wait for 0.2 min with vials fi lled with ultrapure water. This 
step dips the capillary in water to protect against sample car-
ryover. Change the rinse water vials if they are contaminated. 
  4.  Separation step: 5 min from gel buffer vial to gel buffer vial 
(Gel-S vial for separation). The applied voltage should be 
30 kV, with NORMAL polarity (cathode at the detection side) 
with 0.17 min ramp time. 
3.7.3  Performing 
the Rapid CE-LIF Analysis 
for High- Throughput 
Screening
 Fig. 2  High-resolution capillary electrophoresis profi ling of IgG N-glycans. Conditions: capillary, N–CHO neutral- 
coated capillary (effective length, 50 cm; total length, 60 cm); separation buffer, N–CHO carbohydrate separa-
tion buffer; applied electric fi eld, 500 V/cm; separation temperature, 25 °C; pressure injection, 6.89 kPa for 5 s. 
The different glycans have been represented with cartoons based on the Oxford symbol notation with embed-
ded linkage information [ 11 ] 
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  5.  Autozero at 1.0 min. 
  6.  End at 5.0 min. 
  7.  An example of a rapid CE-LIF analysis of APTS-labeled IgG 
N-glycans performed on 10 cm separation length is shown in 
Fig.  3 with the corresponding glycan structures of the peaks. 
4  Notes 
  1.  If the sample concentration is less than 2 mg/mL, pre- 
concentrate before starting the procedure. 
  2.  Make sure that all the liquid passed through the membrane 
after the last step. If not, spin it again. 
  3.  Never use higher  g -forces for the inverted cartridge as it can 
destroy the membrane. 
  4.  When vortexing, always hold the fi ltration device vertically. 
  5.  Do not discard the fl ow through because it contains the 
released N-glycans. 
  6.  Always work with NaBH 3 CN in the fume hood! 
  7.  Always prepare fresh acetonitrile solutions. 
 Fig. 3  Rapid capillary electrophoresis profi ling of IgG N-glycans. Conditions: same as in Fig.  2 with the effective 
separation length of 10 cm 
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